| Lastest Insider Transactions Of ARS Pharmaceuticals, Inc. ( SPRY ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-04-16 | Sell | 100,000 | 9.28 | 928,005 | 2024-04-17 18:42:32 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-04-16 | Sell | 100,000 | 9.28 | 928,005 | 2024-04-17 18:40:40 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-04-09 | Sell | 100,000 | 9.28 | 927,735 | 2024-04-10 17:39:55 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-04-09 | Sell | 100,000 | 9.28 | 927,735 | 2024-04-10 17:36:54 |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior 10% Owner | 2024-03-25 | Buy | 1,401,299 | 9.48 | 13,289,410 | 2024-03-27 19:37:52 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-03-22 | Sell | 97,610 | 9.12 | 890,322 | 2024-03-26 18:48:19 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-03-22 | Sell | 97,610 | 9.12 | 890,322 | 2024-03-26 18:47:24 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-03-19 | Sell | 2,390 | 9.03 | 21,572 | 2024-03-21 21:51:24 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-03-19 | Sell | 2,390 | 9.03 | 21,572 | 2024-03-21 21:50:32 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-03-13 | Sell | 100,000 | 9.14 | 913,681 | 2024-03-15 19:55:07 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-03-13 | Sell | 100,000 | 9.14 | 913,681 | 2024-03-15 19:52:03 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-02-29 | Sell | 3,782 | 9.02 | 34,101 | 2024-03-01 20:21:36 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-02-29 | Sell | 3,782 | 9.02 | 34,101 | 2024-03-01 20:17:51 |
| SPRY | ARS Pharmaceuticals, Inc. | Tanimoto Sarina | CHIEF MEDICAL OFFICER 10% Owner | 2024-02-26 | Sell | 99,478 | 9.02 | 897,368 | 2024-02-28 21:08:51 |
| SPRY | ARS Pharmaceuticals, Inc. | Lowenthal Richard E | PRESIDENT AND CEO 10% Owner | 2024-02-26 | Sell | 99,478 | 9.02 | 897,368 | 2024-02-28 21:04:42 |
| SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | Chief Legal Officer | 2023-09-28 | Buy | 86,258 | 3.71 | 319,954 | 2023-10-02 16:23:09 |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2023-09-21 | Buy | 2,700,000 | 3.03 | 8,183,526 | 2023-09-25 16:30:22 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-09-01 | Sell | 100,000 | 7.71 | 770,520 | 2023-09-05 20:04:41 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-09-01 | Option Exercise | 100,000 | 1.27 | 127,000 | 2023-09-05 20:04:41 |
| SPRY | ARS Pharmaceuticals, Inc. | RA CAPITAL MANAGEMENT, L.P. | Directior | 2023-08-29 | Buy | 3,750,000 | 6.20 | 23,250,000 | 2023-08-31 17:26:46 |
| SPRY | ARS Pharmaceuticals, Inc. | ORBIMED ADVISORS LLC | Directior | 2023-08-29 | Buy | 500,000 | 6.20 | 3,100,000 | 2023-08-31 17:26:17 |
| SPRY | ARS Pharmaceuticals, Inc. | Thompson Peter A. | Directior | 2023-08-29 | Buy | 500,000 | 6.20 | 3,100,000 | 2023-08-31 17:18:44 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-08-03 | Sell | 45,004 | 7.03 | 316,489 | 2023-08-07 17:05:58 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-08-03 | Option Exercise | 45,004 | 1.27 | 57,155 | 2023-08-07 17:05:58 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-08-01 | Sell | 54,996 | 7.12 | 391,841 | 2023-08-03 18:03:20 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-08-01 | Option Exercise | 54,996 | 1.27 | 69,845 | 2023-08-03 18:03:20 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-07-07 | Sell | 8,858 | 6.36 | 56,372 | 2023-07-07 20:16:09 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-07-07 | Option Exercise | 8,858 | 1.27 | 11,250 | 2023-07-07 20:16:09 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-07-03 | Sell | 91,142 | 6.48 | 590,453 | 2023-07-06 20:55:41 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-07-03 | Option Exercise | 91,142 | 1.27 | 115,750 | 2023-07-06 20:55:41 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-06-01 | Sell | 100,000 | 6.84 | 684,041 | 2023-06-02 19:48:08 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2023-06-01 | Option Exercise | 100,000 | 1.27 | 127,000 | 2023-06-02 19:48:08 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2022-11-09 | Sell | 143,896 | 5.42 | 780,579 | 2023-05-10 16:53:46 |
| SPRY | ARS Pharmaceuticals, Inc. | Shawver Laura | Directior | 2022-11-09 | Option Exercise | 100,000 | 1.27 | 127,000 | 2023-05-10 16:53:46 |
